Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Transplanted ALDHhiSSClo neural stem cells generate motor neurons and delay disease progression of nmd mice, an animal model of SMARD1

8 Dec 2005

Abstract excerpt

Spinal muscular atrophy with respiratory distress type 1 (SMARD1) is an infantile autosomal-recessive motor neuron disease caused by mutations in the immunoglobulin micro-binding protein 2. We investigated the potential of a spinal cord neural stem cell population isolated on the basis of aldehyde dehydrogenase (ALDH) activity to modify disease progression of nmd mice, an animal model of SMARD1. ALDH(hi)SSC(lo)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetics and Neurodevelopmental Disorders
Share to Neurogenesis and neuroplasticity mechanisms
Share to Neurogenetic and Muscular Disorders Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 16339214
DOI: 10.1093/hmg/ddi446

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Transplanted ALDHhiSSClo neural stem cells generate motor neurons and delay disease progression of nmd mice, an animal model of SMARD1PMID 16339214Read ↗

Motoneuron transplantation rescues the phenotype of SMARD1 (spinal muscular atrophy with respiratory distress type 1).Semantic proximity Read ↗

Clinical and molecular features and therapeutic perspectives of spinal muscular atrophy with respiratory distress type 1Semantic proximity Read ↗

iPSC-Derived Neural Stem Cells Act via Kinase Inhibition to Exert Neuroprotective Effects in Spinal Muscular Atrophy with Respiratory Distress Type 1Semantic proximity Read ↗

Isogenic patient-derived organoids reveal early neurodevelopmental defects in spinal muscular atrophy initiationSemantic proximity Read ↗

Transcriptome Profiling of Spinal Muscular Atrophy Motor Neurons Derived from Mouse Embryonic Stem CellsSemantic proximity Read ↗

Global Transcriptome Profile of the Developmental Principles of in Vitro iPSC-to-Motor Neuron DifferentiationSemantic proximity Read ↗

Clinically relevant mouse models of severe spinal muscular atrophy with respiratory distress type 1.Semantic proximity Read ↗

Spinal muscular atrophy with respiratory distress type 1: Clinical phenotypes, molecular pathogenesis and therapeutic insights.Semantic proximity Read ↗

Embryonic stem cell-derived neural stem cells improve spinal muscular atrophy phenotype in mice.Semantic proximity Read ↗

Neural stem cell transplantation can ameliorate the phenotype of a mouse model of spinal muscular atrophy.Semantic proximity Read ↗

Hypoimmunogenic human motor neurons induced from iPSCs in vivo substantially ameliorate ALS disease in large animal modelsSemantic proximity Read ↗

An isogenic human iPSC model unravels neurodevelopmental abnormalities in SMASemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.